The high-stakes nature of cancer care, coupled with rapid scientific advancements and increasing payer and regulatory pressures, demands a specialized approach beyond traditional market access strategies.
Shana Gunderson Hua, PharmD; Nancy Pham, PharmD; and Pete Vaccaro
Advertisement
Articles by Shana Gunderson Hua, PharmD; Nancy Pham, PharmD; and Pete Vaccaro
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
3
What Governance Resets Should Pharma Companies Take in Response to AI?
4
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
5